Chronic Nicotine Administration Improves Attention While Nicotine Withdrawal Induces Performance Deficits in the 5-choice Serial Reaction Time Task in Rats

Overview

Journal Pharmacol Biochem Behav

Publisher Elsevier

Specialties Biochemistry
Pharmacology
Psychology
Social Sciences

Date 2007 Jun 22

PMID 17582477

Citations 53

Authors

Svetlana Semenova

Ian P Stolerman

Athina Markou

Affiliations

Soon will be listed here.

Abstract

Nicotine appears to enhance attention, while nicotine withdrawal leads to attentional deficits in humans that are ameliorated with nicotine administration. However, there has been much debate as to whether nicotine improves performance under baseline conditions, or only ameliorates attentional deficits. Thus, we studied the effects of acute and chronic nicotine administration and nicotine withdrawal on attentional performance in the 5-choice serial reaction time task (5-CSRTT) in Wistar and Sprague Dawley (SD) rats under baseline conditions. Wistar rats performed with higher accuracy compared to SD rats. Acute nicotine administration induced small increases in accuracy and correct responses, impulsivity and speed of responding, and decreases in omission errors. These effects were more pronounced in less accurate rats or after task modifications were implemented to disrupt the rats' performance. Chronic nicotine administration via minipumps consistently increased accuracy during days 4-6 of nicotine infusion after the effect of nicotine on impulsivity during days 1-3 dissipated. By contrast, nicotine withdrawal induced decreases in correct responses, and increases in omissions and latencies to respond, but had no effect on accuracy. These results provide evidence that chronic, but not acute, nicotine administration induced accuracy improvement under baseline conditions, while nicotine withdrawal produced some limited performance deficits.

Citing Articles

Bidirectional relationship between attentional deficits and escalation of nicotine intake in male rats.

Vouillac-Mendoza C, Ahmed S, Guillem K Psychopharmacology (Berl). 2024; 241(9):1895-1903.

PMID: 38743111 DOI: 10.1007/s00213-024-06604-x.

Ebselen prevents cigarette smoke-induced cognitive dysfunction in mice by preserving hippocampal synaptophysin expression.

De Luca S, Brassington K, Chan S, Dobric A, Mou K, Seow H J Neuroinflammation. 2022; 19(1):72.

PMID: 35351173 PMC: 8966248. DOI: 10.1186/s12974-022-02432-y.

Conservation of mechanisms regulating emotional-like responses on spontaneous nicotine withdrawal in zebrafish and mammals.

Ponzoni L, Melzi G, Marabini L, Martini A, Petrillo G, Teh M Prog Neuropsychopharmacol Biol Psychiatry. 2021; 111:110334.

PMID: 33905756 PMC: 8380689. DOI: 10.1016/j.pnpbp.2021.110334.

Rodent models for nicotine withdrawal.

Chellian R, Behnood-Rod A, Bruijnzeel D, Wilson R, Pandy V, Bruijnzeel A J Psychopharmacol. 2021; 35(10):1169-1187.

PMID: 33888006 PMC: 8526373. DOI: 10.1177/02698811211005629.

Differential Effects of Nicotine and Nicotine Withdrawal on Fear Conditioning in Male Rats.

Robble M, Holloway I, Ridener E, Webber C, Caine S, Meloni E Int J Neuropsychopharmacol. 2020; 23(7):469-479.

PMID: 32242615 PMC: 7387768. DOI: 10.1093/ijnp/pyaa024.

References

Kerr J, Sherwood N, Hindmarch I . Separate and combined effects of the social drugs on psychomotor performance. Psychopharmacology (Berl). 1991; 104(1):113-9. DOI: 10.1007/BF02244564. View

Hindmarch I, Kerr J, Sherwood N . Effects of nicotine gum on psychomotor performance in smokers and non-smokers. Psychopharmacology (Berl). 1990; 100(4):535-41. DOI: 10.1007/BF02244008. View

Perkins K, Grobe J, Epstein L, Caggiula A, STILLER R, Jacob R . Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav. 1993; 45(2):375-81. DOI: 10.1016/0091-3057(93)90254-q. View

Heishman S, Snyder F, Henningfield J . Performance, subjective, and physiological effects of nicotine in non-smokers. Drug Alcohol Depend. 1993; 34(1):11-8. DOI: 10.1016/0376-8716(93)90041-n. View

Perkins K, Grobe J, Fonte C, Goettler J, Caggiula A, REYNOLDS W . Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther. 1994; 270(2):628-38. View

Schulteis G, Markou A, GOLD L, Stinus L, Koob G . Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther. 1994; 271(3):1391-8. View

Koelega H . Stimulant drugs and vigilance performance: a review. Psychopharmacology (Berl). 1993; 111(1):1-16. DOI: 10.1007/BF02257400. View

Warburton D, Arnall C . Improvements in performance without nicotine withdrawal. Psychopharmacology (Berl). 1994; 115(4):539-42. DOI: 10.1007/BF02245578. View

Stolerman I, Mirza N, Shoaib M . Nicotine psychopharmacology: addiction, cognition and neuroadaptation. Med Res Rev. 1995; 15(1):47-72. DOI: 10.1002/med.2610150105. View

10.

Muir J, Everitt B, Robbins T . Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology (Berl). 1995; 118(1):82-92. DOI: 10.1007/BF02245253. View

11.

Bates T, Mangan G, Stough C, Corballis P . Smoking, processing speed and attention in a choice reaction time task. Psychopharmacology (Berl). 1995; 120(2):209-12. DOI: 10.1007/BF02246195. View

12.

Levin E, Conners C, Sparrow E, Hinton S, Erhardt D, Meck W . Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl). 1996; 123(1):55-63. DOI: 10.1007/BF02246281. View

13.

Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell M . Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl). 1996; 127(1):31-8. DOI: 10.1007/BF02805972. View

14.

Foulds J, Stapleton J, Bell N, Swettenham J, Jarvis M, Russell M . Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend. 1997; 44(2-3):105-15. DOI: 10.1016/s0376-8716(96)01327-0. View

15.

Warburton D, Mancuso G . Evaluation of the information processing and mood effects of a transdermal nicotine patch. Psychopharmacology (Berl). 1998; 135(3):305-10. DOI: 10.1007/s002130050514. View

16.

Watkins S, Koob G, Markou A . Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998; 393(6680):76-9. DOI: 10.1038/30001. View

17.

Mirza N, Stolerman I . Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berl). 1998; 138(3-4):266-74. DOI: 10.1007/s002130050671. View

18.

Levin E, Conners C, Silva D, Hinton S, Meck W, March J . Transdermal nicotine effects on attention. Psychopharmacology (Berl). 1998; 140(2):135-41. DOI: 10.1007/s002130050750. View

19.

Mumenthaler M, Taylor J, OHara R, Yesavage J . Influence of nicotine on simulator flight performance in non-smokers. Psychopharmacology (Berl). 1998; 140(1):38-41. DOI: 10.1007/s002130050736. View

20.

White H, Levin E . Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology (Berl). 1999; 143(2):158-65. DOI: 10.1007/s002130050931. View